We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg (IPEC-EFV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00533390
Recruitment Status : Terminated (Lack of financial support and low inclusion rate)
First Posted : September 21, 2007
Last Update Posted : November 10, 2015
Ministry of Health, Brazil
Information provided by (Responsible Party):
Valeria Cavalcanti Rolla, Oswaldo Cruz Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2012
  Study Completion Date : October 2012